Thursday, April 30, 2020 11:23:11 AM
CAUTION ADVISED SCAM PR IMHO SCAM ALERT IMHO
I read the PR and went to the FDA site
---IT APPEARS THAT - THEY DID NOT SUBMIT THE TEST --- JUST AS I SURMISED ---
AND J& J AND EVERYONE ELSE IS GETTING MORE AND MORE TESTING APPROVED EVERY DAY
EPIC FAIL AND CRASH ON THE WAY --- IMHO as my best guess do your own research call the company.... not advice to buy or sell I sold at the low so not in a position to give advice Good Luck
What Does Industry Gain from Participating in the Emerging Technology Program?
Participants in the Emerging Technology Program gain the following benefits:
https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/emerging-technology-program
Pre-submission face-to-face interactions with ETT members and review staff to answer technical and regulatory questions during the development and adoption of the proposed technology
Opportunity for early interactions with the ETT and review staff on the proposed technology to gather feedback in preparation for a regulatory submission
Through the program, industry representatives can meet with Emerging Technology Team (ETT) members to discuss, identify, and resolve potential technical and regulatory issues regarding the development and implementation of a novel technology prior to filing a regulatory submission.
I read the PR and went to the FDA site
---IT APPEARS THAT - THEY DID NOT SUBMIT THE TEST --- JUST AS I SURMISED ---
AND J& J AND EVERYONE ELSE IS GETTING MORE AND MORE TESTING APPROVED EVERY DAY
EPIC FAIL AND CRASH ON THE WAY --- IMHO as my best guess do your own research call the company.... not advice to buy or sell I sold at the low so not in a position to give advice Good Luck
What Does Industry Gain from Participating in the Emerging Technology Program?
Participants in the Emerging Technology Program gain the following benefits:
https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/emerging-technology-program
Pre-submission face-to-face interactions with ETT members and review staff to answer technical and regulatory questions during the development and adoption of the proposed technology
Opportunity for early interactions with the ETT and review staff on the proposed technology to gather feedback in preparation for a regulatory submission
Through the program, industry representatives can meet with Emerging Technology Team (ETT) members to discuss, identify, and resolve potential technical and regulatory issues regarding the development and implementation of a novel technology prior to filing a regulatory submission.
Recent BNBX News
- BNB Plus Corp. Completes Historic $1.2 Million LineaDNA™ Order • Business Wire • 04/23/2026 11:00:00 AM
- BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value • Business Wire • 04/20/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:09:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:08:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:07:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:14 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 03/25/2026 12:09:48 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/24/2026 08:15:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:06:00 PM
- BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform • Business Wire • 03/18/2026 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/12/2026 09:24:23 PM
- BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers • Business Wire • 02/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:16:58 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/13/2026 07:49:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 09:32:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:11:07 PM
- BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director • Business Wire • 02/05/2026 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/30/2026 09:06:16 PM
- Digital Asset Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 01/28/2026 01:35:00 PM
- BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th • Business Wire • 01/27/2026 01:00:00 PM
- BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th • GlobeNewswire Inc. • 01/27/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:10:46 PM
